A variant allele of CYP2A13 (CYP2A13*2) was previously found to be associated with a lower incidence of lung adenocarcinoma in smokers and was associated with a lower level of expression compared to the CYP2A13*1 allele [75]. This evidence concerns the gene CYP2A13 and lung adenocarcinoma.